AVX-901 (AlphaVax)

N/A

Report date: 2026/05/13 09:17:15

Base Information

Drug NameAVX-901 (AlphaVax)

Drug Alias NameVRP-HER2VRP HER2 ECDTMHER2 VRPDUKE-002-VRPHUHER2-ECD+TM +[7]

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > self-amplifying RNA vaccineVaccines > Application > Therapeutic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAlphavax Inc Duke University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesDuke University

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A